9th ENEA Workshop

9.45 am - 1.15 pm

Club hypophyse - changer les paradigmes : nouvelles vues sur les mécanismes physiopathologiques de l’hypothalamus

Chairs : G. Raverot and T. Brue

9.45 – 10.00 am Mot de bienvenue – G. Raverot and T. Brue France
10.00 – 10.30 am Agonistes du GLP-1 et fonctions hypothalamiques – B. Gatta Cheriffi France
10.30 – 11.00 am Applications cliniques et efficacité des antagonistes de l’ACTH ou de la CRH – O. Chabre France
11.00 - 11.30 am Kisspeptine et activation de l’axe gonadotrope – L. Maione France
11.30 – 12.00 am Les fonctions biologiques de la TRH : hypothyroïdie centrale et au-delà – P. Rodien France

1.15 – 2.00 pm

Welcome and introduction / ENEA studies

2.00 - 3.30 pm

Changes in diagnostic paradigms

Chairs : C. Villa and P. Petrossians

2.00 – 2.15 pm State of the art: Classifying pituitary tumors – C. Villa France
2.15 – 2.35 pm Old and new biomarkers of cortisol excess – A. Tabarin France
2.35 – 2.55 pm Vasopressin deficiency diagnosis – M. Christ-Crain Switzerland
2.55 – 3.15 pm Is OGTT still useful in acromegaly? – G. Occhi Italy
3.15 – 3.30 pm Q & A

3.30 - 4.00 pm

Break with poster session and exhibition visit

4.00 - 4.30 pm

Plenary

Chairs : R. Luque and A. Barlier

4.00 – 4.30 pm Somatic mutations in pituitary tumors – M. Theodoropoulou Germany

4.30 - 5.00 pm

Plenary

Chairs : C. Andoniadou and F. Castinetti

4.30 – 5.00 pm Pituitary transcription factors, where are we? – S. Camper USA

5.00 - 5.45 pm

Controversy

Chairs : M. Puig Domingo and P. Chanson

Dopamine agonists should not be the first line treatment of prolactinomas – N. Biermasz and P. Nomikos The Netherlands and Greece

5.45 - 6.30 pm

Prize Ceremony

Chairs : D. Carvalho and M. Korbonits

Rolf Gaillard Prize

8.15 - 9.45 am

Improving the diagnostic strategy of Cushing’s disease

Chairs : M. Buchfelder and M. Christ-Crain

8.15 – 8.30 am State of the Art : Is imaging necessary to operate CD? – M. Buchfelder Germany
8.30 – 8.50 am 7T MRI – B. Testud France
8.50 – 9.10 am PET-MRI in pituitary tumors – M. Gurnell UK
9.10 – 9.30 am How to live without CRH? – M. Puig Domingo Spain
9.30 – 9.45 amQ & A

9.45 - 10.15 am

Break with poster session and exhibition visit

10.15 - 10.45 am

Plenary

Chairs : M. Korbonits and T. Brue

Growth hormone receptor antagonists, from discovery to recent use – J. Kopchick USA

10.45 - 12.15 am

Multiomics in NET management: from bench to bedside

Chairs : G. Assie and F. Gatto

10.45 – 11.00 am State of the art: Multiomics classification of pituitary tumors – G. Assie France
11.00 – 11.20 am Circulating non coding RNA biomarkers of endocrine tumors – H. Butz Hungary
11.20 – 11.35 am Proteomics – T. Skoglund Sweden
11.35 – 12.00 am Tadopathy as a cause of gigantism – A. Daly Belgium
12.00 – 12.15 am Q & A

12.15 - 12.45 pm

Crinetics Industry Sponsored Symposium : Small Molecule Drug Discovery - How to Build a Pipeline

S. Betz, PhD Co-Founder and CSO, Crinetics Pharmaceuticals

12.45 - 1.30 pm

Break - Lunch

1.30 – 2.30 pm

Industry Sponsored Symposium Recordati : Translating guidelines into practice - Personalised approaches for optimising outcomes in patients with acromegaly

13:30 – 13:35 pm Welcome and introduction – M. Fleseriu USA
13:35 – 13:55 pm Acromegaly treatment guidelines: From defining biochemical remission to individualising medical therapy – M. Fleseriu and F. Castinetti USA and France
13:55 – 14:05 pm When to personalise therapy – D. Ferone Italy
14:05 – 14:23 pm Implications for the clinical management of patients resistant to first-generation SRLs – M. Gadelha, including discussion with M. Fleseriu, D. Ferone and F. Castinetti Brasil
14:23 – 14:30 pmQ & A – M. Gadelha, M. Fleseriu, D. Ferone and F. Castinetti Brasil, USA, Italy and France

2.30 - 4.00 pm

New kids on the block in pituitary function and interactions

Chairs : P. Mollard and S. Chiloiro

2.30 – 2.45 pm State of the art: Pituitary cells function as a network – P. Mollard France
2.45 – 3.05 pm The importance of Rhythm in corticotroph cells – S. Lightman UK
3.05 – 3.25 pm Microenvironment in pituitary tumors – R. Luque Spain
3.25 – 3.45 pm Pituitary stem cells – C. Andoniadou UK
3.45 – 4.00 pm Q & A

4.00 - 5.00 pm

Break with poster session and exhibition visit

4.00 - 5.00 pm

Industry Sponsored Symposium : Camurus

5.00 – 6.00 pm

EYRC Oral communication

Chair : K. Zibar and A. C. Fuentes-Fayos

8.30 - 10.00 am

Advances in the management of pituitary tumors

Chairs : N. Karavitaki and A. Pereira

8.30 – 8.45 am State of the art : Resetting the natural history of macroNFPA – N. Karavitaki UK
8.45 – 9.05 am Can acromegaly be controlled in all cases? – S. Chiloiro Italy
9.05 – 9.25 am How to avoid surgery in craniopharyngioma? – E. Jouanneau France
9.25 – 9.45 am Somatostatin receptors, from old to new concepts – D. Ferone Italy
9.45 – 10.00 amQ & A

10.00 - 10.30 am

Break with poster session and exhibition visit

10.00 - 10.30 am

Poster Tour

Chairs : T. Brue and F. Castinetti

Presentation of the 10 bests Posters | In The Poster area – T. Brue and F. Castinetti France

10.30 - 11.00 am

Plenary

Chairs : J. Vassalo and N. De Roux

Hypogonadotrophic hypogonadism – N. Pitteloud Switzerland

11.00 - 12.30 am

Controlling the secretion is not the only aim of management

Chairs : E. Valassi and G. Raverot

11.00 – 11.15 am State of the art: Unmet needs in patients in remission of pituitary tumors – E. Valassi Spain
11.15 – 11.35 am Altered quality of life in pituitary tumors, it begins at diagnosis – T. Marmorat France
11.35 – 11.55 am Neurocognitive consequences of pituitary tumors – A. Pereira The Netherlands
11.55 – 12.15 am Living with a pituitary tumor – J. De Graaf The Netherlands
12.15 – 12.30 am Q & A

12.30 - 1.15 pm

Break - Lunch

12.30 - 1.15 pm

EYRC Poster Session

Chairs : ENEA Young Researcher Committee Members

EYRC Poster Session | In The Poster area

1.15 – 2.15 pm

EYRC Symposium

Chairs : F. Chasseloup and G. Trivellin

1.15 – 1.35 pm Artificial Intelligence in the Diagnosis of Acromegaly – K. Vouzouneraki Suède
1.35 – 1.55 pm Radiomics and Imaging Biomarkers for Pituitary Tumors – L. Ugga Italy
1.55 – 2.15 pm Human Induced Pluripotent Stem Cells (hiPSC) – G. Ascone France

2.15 – 2.45 pm

Plenary

Chairs : K. Alexandraki and T. Cuny

Aberrant hormone receptors in pituitary tumors – P. Kamenicky France

2.45 - 3.30 pm

Controversies

Chairs : N. Biermasz and L. Naves

Surgery or conservative management for pituitary apoplexy – P. Chanson and W. Van Furth France and The Netherlands

9.45 am - 1.15 pm

Club hypophyse - changer les paradigmes : nouvelles vues sur les mécanismes physiopathologiques de l’hypothalamus

Chairs : G. Raverot and T. Brue

1.15 – 2.00 pm

Welcome and introduction / ENEA studies

2.00 - 3.30 pm

Changes in diagnostic paradigms

Chairs : C. Villa and P. Petrossians

3.30 - 4.00 pm

Break with poster session and exhibition visit

4.00 - 4.30 pm

Plenary

Chairs : R. Luque and A. Barlier

4.30 - 5.00 pm

Plenary

Chairs : C. Andoniadou and F. Castinetti

5.00 - 5.45 pm

Controversy

Chairs : M. Puig Domingo and P. Chanson

5.45 - 6.30 pm

Prize Ceremony

Chairs : D. Carvalho and M. Korbonits

8.15 - 9.45 am

Improving the diagnostic strategy of Cushing’s disease

Chairs : M. Buchfelder and M. Christ-Crain

9.45 - 10.15 am

Break with poster session and exhibition visit

10.15 - 10.45 am

Plenary

Chairs : M. Korbonits and T. Brue

10.45 - 12.15 am

Multiomics in NET management: from bench to bedside

Chairs : G. Assie and F. Gatto

12.15 - 12.45 pm

Crinetics Industry Sponsored Symposium : Small Molecule Drug Discovery - How to Build a Pipeline

S. Betz, PhD Co-Founder and CSO, Crinetics Pharmaceuticals

12.45 - 1.30 pm

Break - Lunch

1.30 – 2.30 pm

Industry Sponsored Symposium Recordati : Translating guidelines into practice - Personalised approaches for optimising outcomes in patients with acromegaly

2.30 - 4.00 pm

New kids on the block in pituitary function and interactions

Chairs : P. Mollard and S. Chiloiro

4.00 - 5.00 pm

Break with poster session and exhibition visit

4.00 - 5.00 pm

Industry Sponsored Symposium : Camurus

5.00 – 6.00 pm

EYRC Oral communication

Chair : K. Zibar and A. C. Fuentes-Fayos

8.30 - 10.00 am

Advances in the management of pituitary tumors

Chairs : N. Karavitaki and A. Pereira

10.00 - 10.30 am

Break with poster session and exhibition visit

10.00 - 10.30 am

Poster Tour

Chairs : T. Brue and F. Castinetti

10.30 - 11.00 am

Plenary

Chairs : J. Vassalo and N. De Roux

11.00 - 12.30 am

Controlling the secretion is not the only aim of management

Chairs : E. Valassi and G. Raverot

12.30 - 1.15 pm

Break - Lunch

12.30 - 1.15 pm

EYRC Poster Session

Chairs : ENEA Young Researcher Committee Members

1.15 – 2.15 pm

EYRC Symposium

Chairs : F. Chasseloup and G. Trivellin

2.15 – 2.45 pm

Plenary

Chairs : K. Alexandraki and T. Cuny

2.45 - 3.30 pm

Controversies

Chairs : N. Biermasz and L. Naves

3.30 – 4.00 pm

EYRC Best Abstracts prizes and Workshop conclusions

Chair : ENEA Young Researcher Committee Member

Logistics Secretariat

Event Venue

Important Links

1.15 – 2.00 pm Welcome and introduction / ENEA studies

3.30 - 4.00 pm Break with poster session and exhibition visit

9.45 - 10.15 am Break with poster session and exhibition visit

12.15 - 12.45 pm Crinetics Industry Sponsored Symposium : Small Molecule Drug Discovery - How to Build a Pipeline S. Betz, PhD Co-Founder and CSO, Crinetics Pharmaceuticals

12.45 - 1.30 pm Break - Lunch

4.00 - 5.00 pm Break with poster session and exhibition visit

4.00 - 5.00 pm Industry Sponsored Symposium : Camurus

5.00 – 6.00 pm EYRC Oral communication Chair : K. Zibar and A. C. Fuentes-Fayos

10.00 - 10.30 am Break with poster session and exhibition visit

12.30 - 1.15 pm Break - Lunch

3.30 – 4.00 pm EYRC Best Abstracts prizes and Workshop conclusions Chair : ENEA Young Researcher Committee Member

1.15 – 2.00 pm

Welcome and introduction / ENEA studies

3.30 - 4.00 pm

Break with poster session and exhibition visit

9.45 - 10.15 am

Break with poster session and exhibition visit

12.15 - 12.45 pm

Crinetics Industry Sponsored Symposium : Small Molecule Drug Discovery - How to Build a Pipeline

S. Betz, PhD Co-Founder and CSO, Crinetics Pharmaceuticals

12.45 - 1.30 pm

Break - Lunch

4.00 - 5.00 pm

Break with poster session and exhibition visit

4.00 - 5.00 pm

Industry Sponsored Symposium : Camurus

5.00 – 6.00 pm

EYRC Oral communication

Chair : K. Zibar and A. C. Fuentes-Fayos

10.00 - 10.30 am

Break with poster session and exhibition visit

12.30 - 1.15 pm

Break - Lunch

3.30 – 4.00 pm

EYRC Best Abstracts prizes and Workshop conclusions

Chair : ENEA Young Researcher Committee Member